Avenacy launches two new products in the US: fosaprepitant for injection and fulvestrant injection. Fosaprepitant for injection is a generic alternative for Emend, indicated for preventing nausea and vomiting during cancer chemotherapy. Fulvestrant injection is a generic for Faslodex, used for advanced breast cancer treatment. Both products feature highly differentiated packaging and labeling to support accurate medication selection.